Skip to main content
logo
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
11.11
-0.04 (-0.36%)
May 5, 2026, 12:20 PM EDT - Market open

Telix Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3,7532,5375,155---
Market Cap Growth
-30.97%-50.78%----
Enterprise Value
4,1032,8445,062000
Last Close Price
11.117.4915.40---
PE Ratio
--354.98157.79---
PS Ratio
4.673.169.98---
PB Ratio
9.036.1114.61---
P/TBV Ratio
9.046.0915.06---
P/FCF Ratio
--59.03114.22---
P/OCF Ratio
--146.7395.03---
EV/Sales Ratio
5.103.549.80---
EV/EBITDA Ratio
126.3955.5683.72---
EV/EBIT Ratio
212.7195.5191.73---
EV/FCF Ratio
--66.16112.16---
Debt / Equity Ratio
1.081.080.980.110.120.88
Debt / EBITDA Ratio
9.139.135.960.78-0.12-0.06
Debt / FCF Ratio
-10.87-10.877.980.49-0.15-0.04
Net Debt / Equity Ratio
0.780.78-0.23-0.71-1.32-9.03
Net Debt / EBITDA Ratio
6.356.35-1.32-4.751.220.48
Net Debt / FCF Ratio
-7.57-7.57-1.77-2.971.490.32
Asset Turnover
0.760.760.851.480.860.05
Inventory Turnover
12.4312.4310.1914.0610.711.24
Quick Ratio
1.171.172.571.141.821.09
Current Ratio
1.431.432.781.412.021.25
Return on Equity (ROE)
-1.85%-1.85%14.83%5.40%-252.89%-187.51%
Return on Assets (ROA)
1.83%1.83%10.08%1.85%-46.61%-33.17%
Return on Invested Capital (ROIC)
3.23%3.23%25.36%5.04%-121.49%-68.10%
Return on Capital Employed (ROCE)
3.57%3.57%12.27%7.87%-74.58%-42.19%
Earnings Yield
-0.19%-0.28%0.63%---
FCF Yield
-1.15%-1.69%0.88%---
Buyback Yield / Dilution
2.12%2.12%-6.63%-4.21%-10.08%-9.69%
Total Shareholder Return
2.12%2.12%-6.63%-4.21%-10.08%-9.69%
Updated Feb 20, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q